ISTIRATUMAB
UNII XLR461MD3M

Substance Identification & Data

This profile provides standardized clinical and technical data for Istiratumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XLR461MD3M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1509928-04-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XLR461MD3M

CAS Registry Number

1509928-04-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ISTIRATUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C103863

National Cancer Institute reference terminology for clinical and research data.

INN ID

10431

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-106

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Istiratumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ISTIRATUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR/NEUREGULIN RECEPTOR HER3) (HUMAN MONOCLONAL MM-005 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MM-005 LIGHT CHAIN, DIMER

ISTIRATUMAB [INN]

ISTIRATUMAB [USAN]

ISTIRATUMAB [WHO-DD]